OKYO Pharma News

OKYO Pharma | 4: Statement of changes in beneficial ownership of securities-Executive Chairman CERRONE GABRIELE M

Nov 1, 2023 04:15

OKYO Pharma | 4: Statement of changes in beneficial ownership of securities-Director BRANCACCIO JOHN P

Sep 28, 2023 18:15

OKYO Pharma | 4: Statement of changes in beneficial ownership of securities

May 20, 2022 22:35

OKYO Pharma | 4: Statement of changes in beneficial ownership of securities

May 19, 2022 23:14

OKYO Pharma | 4: Statement of changes in beneficial ownership of securities

May 19, 2022 23:14

OKYO Pharma | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer CERRONE GABRIELE M

May 19, 2022 01:38

OKYO Pharma | 4: Statement of changes in beneficial ownership of securities

May 18, 2022 23:37

OKYO Pharma | 3: Initial statement of beneficial ownership of securities-Chief Financial Officer Shah Keeren

May 17, 2022 05:53

OKYO Pharma | 3: Initial statement of beneficial ownership of securities-Director Simon Willy Jules

May 17, 2022 05:52

OKYO Pharma | 3: Initial statement of beneficial ownership of securities

May 17, 2022 05:47

OKYO Pharma | 3: Initial statement of beneficial ownership of securities-Chief Executive Officer JACOB GARY S

May 17, 2022 05:44

OKYO Pharma | 3: Initial statement of beneficial ownership of securities-Executive Chairman CERRONE GABRIELE M

May 17, 2022 05:41

OKYO Pharma | 3: Initial statement of beneficial ownership of securities-Director Denoyer Bernard

May 17, 2022 05:37